Label: ALAHIST D- pheniramine maleate, phenylephrine hcl tablet

  • NDC Code(s): 50991-776-01, 50991-776-02
  • Packager: Poly Pharmaceuticals, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated July 9, 2024

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredient (in each tablet) Purpose

    Pheniramine Maleate 17mg​

    Antihistamine
    Phenylephrine HCl 10mgNasal Decongestant

  • USES

    Temporarily relieves these symptoms due to the
    common cold, hay fever (allergic rhinitis) or other
    upper respiratory allergies:

    •  runny nose
    •  sneezing
    •  itching of the nose or throat
    •  itchy, watery eyes
    •  nasal congestion 
      • reduces swelling of nasal passages
  • WARNINGS

    Do not exceed recommended dosage.

    Do not use this product
    if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or
    emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

    Ask a doctor before use ifyou have

    •  a breathing problem such as emphysema or chronic bronchitis
    •  glaucoma
    •  trouble urinating due to enlargement of the prostate gland
    •  heart disease
    •  high blood pressure
    •  thyroid disease 
    • diabetes

    Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

    When using this product

    •  excitability may occur, especially in children
    •  may cause drowsiness
    •  avoid alcoholic drinks
    •  alcohol, sedatives, and tranquilizers may increase the drowsiness effect
    •  use caution when driving a motor vehicle or operating machinery

    Stop use and ask a doctor if
     nervousness, dizziness, or sleeplessness occur
     symptoms do not improve within 7 days or are accompanied by fever

    If pregnant or breast-feeding, ask a health
    professional before use.

  • DIRECTIONS

    Directions

    Adults and children 12 years of age and over1 tablet every 4 hours, not to exceed 6 tablets in 24 hours

    Children 6 to under 12 years of age

    Children under 6 consult a doctor

    1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours

  • INACTIVE INGREDIENTS

    Inactive ingredients
    Magnesium Stearate, Microcrystalline Cellulose, Natural Yellow, Sodium Starch Glycolate

  • QUESTIONS

    Questions? Comments?
    Call 1-800-882-1041
    Manufactured for:
    Poly Pharmaceuticals
    Huntsville, AL 35763 Rev. 04/17

  • OTHER INFORMATION

    Other information
    Store at 15°-30°C (59°-86°F). Supplied in a tight, light-resistant container with a child-resistant cap. Alahist D Tablets are yellow,debossed "A" bisect "D" on one side and plain on the other.

  • KEEP OUT OF REACH OF CHILDREN

    ​Keep out of reach of children

    ​In case of overdose, get medical help or contact a Poison Control Center right away.

  • PURPOSE

    Antihistamine

    Nasal Decongestant

  • Package Label

    label

    INSERT

  • INGREDIENTS AND APPEARANCE
    ALAHIST D 
    pheniramine maleate, phenylephrine hcl tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50991-776
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENIRAMINE MALEATE (UNII: NYW905655B) (PHENIRAMINE - UNII:134FM9ZZ6M) PHENIRAMINE MALEATE17.5 mg
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
    Product Characteristics
    ColoryellowScore2 pieces
    ShapeOVALSize11mm
    FlavorImprint Code A;D
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50991-776-01100 in 1 BOTTLE; Type 0: Not a Combination Product04/01/2020
    2NDC:50991-776-0212 in 1 BLISTER PACK; Type 0: Not a Combination Product04/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01204/01/2020
    Labeler - Poly Pharmaceuticals, Inc. (198449894)